Novartis AG
History
| Year | Detail |
|---|---|
| 1758 | Johann Rudolf Geigy-Gemuseus has founded J.R. Geigy, a trading company to deal with chemicals, materials, drugs, and dyes in Basel, Switzerland. |
| 1859 | Alexander Clavel have started the production of fuchsine, a synthetic dye in his silk dyeing factory in Switzerland. |
| 1886 | Dr. Alfred Kern and Edouard Sandoz has founded the Kern & Sandoz, a chemical company in Basel, Switzerland. |
| 1900 | Ciba has started the production of its first pharmaceutical substances: Vioform and Salen, an antiseptic and antirheumatic agent. |
| 1917 | Prof. Arthur Stoll has developed a pharmaceutical department to start his research at Sandoz. |
| 1970 | Geigy and CIBA has been merged together to form CIBA-GEIGY. |
| 1996 | The merger between Sandoz and Ciba-Geigy formed Novartis AG. |
| 2002 | Novartis AG unifies and strengthens its global research network by founding the Novartis Institutes for BioMedical Research (NIBR) in the U.S. |
| 2019 | Alcon becomes a standalone trading company while Novartis AG strengthens its focus towards geenric and advanced medicines. |
BCC Research Beacon 